title: [Prevention of arteriosclerosis. Importance of the treatment of arterial hypertension].
abstract: In most European countries and Northern America, cardiovascular diseases induced by atherosclerosis are the most common cause of death in older people. People surviving acute myocardial infarction or stroke suffer often by disabilities or handicaps. The lifelong care of such patients is expensive and plays a major role for increment of costs in public health systems. Prevention of atherosclerosis will reduce cardiovascular morbidity and mortality, enhance quality of life and prolong lifetime of patients. Therefore the worldwide accepted risk factors of atherosclerosis have to be treated consequently and early enough within the meaning of primary prevention. Hypertension is one of the six major cardiovascular risk factors and is defined as elevated blood pressure above 140/90 mmHg. In case of hypertension, diagnostic efforts has to be focussed on detection of additional cardiovascular risk factors, secondary forms of hypertension, end organ damage or associated diseases. All therapeutic strategies are based on life style changes, which cover weight reduction, sodium restriction, controlled alcohol consumption and increment in physical activity. Pharmacotherapy will be added in regard to the global risk of the patient and the success of the life style changes. Selection of antihypertensives and their optimal combination will be determined by associated diseases (compelling indication), side effects and individual response in blood pressure. Goal of treatment is the normalization of blood pressure below 140/90 mmHg independent of age or sex. In diabetics and in case of nephropathy the goal is set lower (below 130/80 mmHg).There is strong evidence that reduction in blood pressure is followed by a decrease in the incidence of myocardial infarction, stroke, heart failure, nephropathy, and even in cardiovascular mortality. The success of antihypertensive therapy is greater in high risk patients like older people, patients with isolated systolic hypertension or diabetics. Risk reduction correlates well with the degree in blood pressure reduction. However, to minimize cardiovascular risk in hypertensives all additional risk factors have to be treated too.
authors.affiliation: Klinik Lazariterhof/Baden-Privatklinik, MEDIAN-Kliniken, Herbert-Hellmann-Allee 44, 79189 Bad Krozingen, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Bönner
authors.forename: D B
authors.initials: DB
authors.lastname: Gysan
authors.forename: G
authors.initials: G
authors.lastname: Sauer
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000401:mortality* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D015897:Comorbidity; D005060:Europe / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000401:mortality* / Q000628:therapy*; D009656:North America / Q000453:epidemiology; D015995:Prevalence; D011322:Primary Prevention / Q000379:methods / Q000706:statistics & numerical data; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents